Traweek James W JR

CIK 00016652992 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001665299

Recent Transactions

50 trades

Other
Apollo Endosurgery, Inc.
Class A common stock
2020-01-02+3,811→ 297,120 total
Other
Apollo Endosurgery, Inc.
Class A common stock
2020-01-02+15,244→ 15,244 total
Other
Apollo Endosurgery, Inc.
Class A common stock
2020-01-02+38,108→ 507,208 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-30+30,000→ 46,645 total
Conversion
REATA PHARMACEUTICALS INC
Class B Common Stock
2019-12-30−30,000→ 155,263 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-12+30,478→ 33,217 total
Conversion
REATA PHARMACEUTICALS INC
Class B Common Stock
2019-12-12−30,478→ 0 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2019-11-18$183.00/sh+40,218→ 3,063,567 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-12-12$59.90/sh+1,418→ 3,023,349 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-12-11$60.07/sh+52,809→ 3,021,931 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-12-10$57.93/sh+26,174→ 2,938,697 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-12-10$58.62/sh+1,078→ 2,939,775 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-12-10$59.53/sh+29,347→ 2,969,122 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-29$28.47/sh+17,000→ 2,912,523 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-28$26.10/sh+200→ 2,895,523 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-27$25.83/sh+15,000→ 2,895,323 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-26$26.06/sh+12,000→ 2,880,323 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-14$24.65/sh+78,275→ 2,868,323 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-13$24.88/sh+121,425→ 2,789,748 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-12-13$23.98/sh+300→ 2,790,048 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2017-06-22+742,289→ 2,668,323 total
Conversion
REATA PHARMACEUTICALS INC
Class B Common Stock
2017-06-22−742,289→ 1,692,857 total
Purchase
REATA PHARMACEUTICALS INC
Class B Common Stock
2017-06-22$25.00/sh+1,200,000→ 2,435,146 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-12-30$21.72/sh+9,392→ 1,926,034 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-12-16$22.99/sh+164,753→ 1,916,642 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-12-15$22.05/sh+2,700→ 1,751,889 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-12-14$21.37/sh+6,189→ 1,749,189 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-08-18$17.32/sh+105,562→ 1,743,000 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-08-17$17.26/sh+144,058→ 1,637,438 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-08-16$16.21/sh+58,600→ 1,493,380 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-30$19.75/sh+100,000→ 632,780 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-29$19.83/sh+63,700→ 532,780 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-28$19.74/sh+900→ 469,080 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-27$19.17/sh+21,968→ 468,180 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-24$19.49/sh+42,526→ 446,212 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-24$18.35/sh+8,909→ 403,686 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-07$17.62/sh+4,220→ 394,777 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-06$17.56/sh+20,000→ 390,557 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01$11.43/sh+56,739→ 167,708 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01$13.22/sh+8,233→ 303,632 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−35→ 380 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−572→ 6,364 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−572→ 6,364 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−110,969→ 1,235,146 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01+16,645→ 16,645 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01+572→ 572 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−7,056→ 78,539 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−2,739→ 30,478 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01$11.00/sh+802,000→ 912,969 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−16,645→ 185,263 total

Companies

Recent Filings

Address

C/O CPMG, INC. 2000 MCKINNEY AVE., SUITE 2125

DALLAS, TX, 75201

View on SEC.gov